ACTIVE

DEVGEN

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

2,9 M €

-35.7% YoY

Revenue

1,1 M €

+19.6% YoY

Equity

128,3 M €

+2.3% YoY

Workforce

2,9 ETP

-14.7% YoY

What does DEVGEN do?

DEVGEN is a Public limited company incorporated in 1997. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 2,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0461.432.562

Incorporation

11/09/1997

Legal form

Public limited company

Registered office

Technologiepark-Zwijnaarde 30
9052 Gent · FlandreSee on map

Contributed capital

135 599 547,70 €

Latest accounts

31/12/2025

Average workforce

2,9 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72109Research and experimental development on natural sciences and engineering 72110Research and experimental development on biotechnology 72190Other research and experimental development on natural sciences and engineering 73100Advertising

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 12 financial years

	2025		2024		2023		2022		2021		2020		2015		2014		2009		2008		2007		2006
Income statement
Revenue	1,1 M €	+19.6%	944,2 k €	-91.1%	10,6 M €	+67.2%	6,3 M €	-7.3%	6,8 M €	+6.0%	6,4 M €	-26.7%	8,8 M €	-6.6%	9,4 M €	+1.5%	9,3 M €	+192%	3,2 M €	-44.0%	5,7 M €	-17.1%	6,8 M €
EBITDA	80,3 k €	+26.5%	63,5 k €	-99.2%	7,8 M €	+767%	899,7 k €	-73.1%	3,3 M €	+348%	747,3 k €	-10.8%	838,0 k €	+78.1%	470,6 k €	+111%	-4,2 M €	+80.6%	-21,7 M €	-66.2%	-13,1 M €	-53.6%	-8,5 M €
Operating result	70,1 k €	+31.6%	53,3 k €	-99.3%	7,3 M €	+1695%	407,0 k €	-86.1%	2,9 M €	+774%	334,1 k €	-49.1%	656,4 k €	+155%	-1,2 M €	+81.9%	-6,6 M €	+73.0%	-24,6 M €	-73.5%	-14,2 M €	-52.4%	-9,3 M €
Net result	2,9 M €	-35.7%	4,6 M €	-49.9%	9,1 M €	+3719%	239,1 k €	-91.7%	2,9 M €	+706%	356,7 k €	-48.2%	689,2 k €	-98.5%	45,7 M €	+814%	-6,4 M €	+72.5%	-23,3 M €	-87.5%	-12,4 M €	-43.6%	-8,6 M €
Balance sheet
Equity	128,3 M €	+2.3%	125,4 M €	+3.8%	120,8 M €	+8.2%	111,7 M €	+0.2%	111,4 M €	+2.6%	108,6 M €	+4.6%	103,8 M €	+0.7%	103,1 M €	+99.5%	51,7 M €	+19.2%	43,4 M €	-34.9%	66,5 M €	+131%	28,8 M €
Total assets	130,9 M €	+0.6%	130,1 M €	+2.9%	126,4 M €	+11.2%	113,7 M €	-0.7%	114,5 M €	+0.7%	113,7 M €	-2.2%	116,2 M €	-2.3%	118,9 M €	+69.1%	70,3 M €	+47.6%	47,6 M €	-33.2%	71,4 M €	+118%	32,8 M €
Cash	–		–		–		–		–		104,4 M €	+404029%	25,8 k €	-74.5%	101,5 k €	-99.7%	37,1 M €	+182%	13,1 M €	-40.4%	22,0 M €	+62.2%	13,6 M €
Debts	2,6 M €	-45.4%	4,7 M €	-15.5%	5,6 M €	+182%	2,0 M €	-33.3%	3,0 M €	+13.9%	2,6 M €	-26.1%	3,5 M €	+3.9%	3,4 M €	-0.5%	3,4 M €	-19.1%	4,2 M €	-11.0%	4,7 M €	+22.5%	3,9 M €
Other
Workforce	2,9 ETP	-14.7%	3,4 ETP	-80.0%	17,0 ETP	-41.2%	28,9 ETP	-3.7%	30,0 ETP	-0.3%	30,1 ETP	-26.0%	40,7 ETP	-10.2%	45,3 ETP	-7.2%	48,8 ETP	-36.1%	76,4 ETP	-14.1%	88,9 ETP	-7.8%	96,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 43 ended

Active mandates

Johan De Dobbelaere

Director · since 30 septembre 2023 · until 29 septembre 2029

Active

Caroline Dierickx

Director · since 30 juin 2020 · until 30 juin 2026

Active

Richard Peletier

Director · since 25 mai 2020 · until 24 mai 2026

Active

Ended mandates

Sabine Drieghe

Director · since 30 juin 2020 · until 06 avril 2023

Ended

Sabine Drieghe

Director · since 30 juin 2020 · until 30 juin 2026

Ended

Richard Peletier

Director · since 26 mai 2020 · until 30 juin 2026

Ended

Wendy Maddelein

Director · since 26 mai 2020 · until 30 septembre 2023

Ended

At this address

Other companies at this address

Company	CBE no.
Confo Therapeutics● Active	0632.474.939
Eastman Chemical Technology● Active	0671.793.393
Syngenta Seeds● Active	0404.599.569

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/07/2026	11/07/2025	09/07/2024	09/07/2024	09/07/2024	09/07/2024
General meeting	30/06/2026	26/06/2025	25/06/2024	27/06/2023	30/06/2022	29/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

34 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	20/07/2026	Dutch	PDF
Full model	31/12/2024	26/06/2025	11/07/2025	Dutch	PDF
Full model	31/12/2023	25/06/2024	09/07/2024	Dutch	PDF
Full modelCorrection	31/12/2022	27/06/2023	09/07/2024	Dutch	PDF
Full model	31/12/2022	27/06/2023	24/10/2023	Dutch	PDF
Full modelCorrection	31/12/2021	30/06/2022	09/07/2024	Dutch	PDF
Full model	31/12/2021	30/06/2022	24/07/2023	Dutch	PDF
Full modelCorrection	31/12/2020	29/06/2021	09/07/2024	Dutch	PDF
Full modelCorrection	31/12/2020	29/06/2021	25/07/2023	Dutch	PDF
Full modelCorrection	31/12/2020	29/06/2021	03/03/2023	Dutch	PDF
Full model	31/12/2020	29/06/2021	30/03/2022	Dutch	PDF
Full modelCorrection	31/12/2019	30/06/2020	24/04/2021	Dutch	PDF
Full model	31/12/2019	30/06/2020	21/02/2021	Dutch	PDF
Full model	31/12/2018	25/06/2019	30/11/2019	Dutch	PDF
Full model	31/12/2017	26/06/2018	24/07/2018	Dutch	PDF
Full model	31/12/2016	27/06/2017	23/11/2017	Dutch	PDF
Full model	31/12/2015	28/06/2016	10/07/2016	Dutch	PDF
Full modelCorrection	31/12/2014	29/06/2015	14/07/2015	Dutch	PDF
Full model	31/12/2014	29/06/2015	30/06/2015	Dutch	PDF
Full model	31/12/2013	27/06/2014	16/07/2014	Dutch	PDF
Full model	31/12/2012	12/07/2013	23/07/2013	Dutch	PDF
m121-f-p	31/12/2012	23/04/2013	24/03/2014	Dutch	PDF
Full model	31/12/2011	01/06/2012	27/06/2012	Dutch	PDF
m120-f-p	31/12/2011	01/06/2012	28/06/2012	Dutch	PDF

View all 34 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 43 ended

Active mandates

Johan De Dobbelaere

Director · since 30 septembre 2023 · until 29 septembre 2029

Active

Caroline Dierickx

Director · since 30 juin 2020 · until 30 juin 2026

Active

Richard Peletier

Director · since 25 mai 2020 · until 24 mai 2026

Active

Ended mandates

Sabine Drieghe

Director · since 30 juin 2020 · until 06 avril 2023

Ended

Sabine Drieghe

Director · since 30 juin 2020 · until 30 juin 2026

Ended

Richard Peletier

Director · since 26 mai 2020 · until 30 juin 2026

Ended

Wendy Maddelein

Director · since 26 mai 2020 · until 30 septembre 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates20/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/09/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/09/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/05/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/11/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/08/2020
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20252,9 M €↓
2024
Annual accounts 20244,6 M €↓
18/09/2024
nominationMike Boonen — vaste vertegenwoordiger
17/06/2024
autre
2023
Annual accounts 20239,1 M €↑
27/06/2023
nominationKPMG Bedrijfsrevisoren BV/SRL — commissaris
27/06/2023
nominationHenk Vandorpe — vaste vertegenwoordiger
2022
Annual accounts 2022239,1 k €↓
2021
Annual accounts 20212,9 M €↑
2020
Annual accounts 2020356,7 k €↓
2015
Annual accounts 2015689,2 k €↓
2014
Annual accounts 201445,7 M €↑
2009
Annual accounts 2009-6,4 M €↑
2008
Annual accounts 2008-23,3 M €↓
2007
Annual accounts 2007-12,4 M €↓
2006
Annual accounts 2006-8,6 M €
11/09/1997
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DEVGEN

Overview

What does DEVGEN do?

Trend over 12 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline